David Mc Gowan,Koen Vandyck,Pierre Jean-Marie Bernard Raboisson
申请号：
BR112012004969
公开号：
BR112012004969A2
申请日:
2010.09.02
申请国别(地区):
BR
年份:
2019
代理人:
摘要：
Inhibitors of HCV replication of formula I including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein R and R&prime； have the meaning as defined herein. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use in HCV therapy.
